Baker Donelson is pleased to announce the addition of Jean Frydman to the Firm's Food and Drug (FDA) Team in our Baltimore office.

Jean brings significant experience handling regulatory compliance matters for both private and publicly held pharmaceutical, medical device, food,

and dietary supplement companies. She has provided strategic legal and compliance reports to boards of directors and serves as a trusted legal adviser to executive management and business leaders. Jean's practice has a particular focus on regulatory strategies, policies and compliance systems, including labeling requirements, Foreign Corrupt Practices Act of 1977 (FCPA) policies, Anti-Kickback FDA inspections and off-label promotions resulting in consent decrees and other litigation.

Prior to joining Baker Donelson, Jean spent more than a decade as general counsel to several major pharmaceutical companies and a retail dietary supplement company. She served as SVP, general counsel and corporate secretary of The Vitamin Shoppe; U.S. general counsel and chief compliance officer at Ferring Pharmaceuticals Inc.; vice president, general counsel and corporate secretary at NovaDel Pharma Inc.; associate general counsel at Pfizer Inc.; senior attorney, product trade and regulations at BASF Corporation; legal/regulatory director at Pharmacia Inc.; and regulatory attorney and senior regulatory specialist at Abbott Laboratories.

Baker Donelson's Food and Drug (FDA) Group has more than 15 attorneys dedicated to navigating complex FDA regulatory matters, including responses to FDA inspections and warning letters, strategic product positioning and client organizational assessments. Our team has a national and international client base, centered on branded over-the-counter and prescription drugs, medical devices, cosmetics, dietary supplements and medical foods.